Core Research

MOTS-c Research Overview

MOTS-c is a 16-residue mitochondrially encoded peptide investigated in metabolic-stress signalling, nuclear gene regulation and, more recently, experimental host defence. These research domains do not have a single interchangeable endpoint. Cell and mouse findings require separate interpretation from human measurements of naturally occurring MOTS-c.

Research Use Only: Core Research supplies MOTS-c presentations for laboratory research, not human or veterinary use. This overview contains no administration, dosing or treatment guidance.

What is MOTS-c and why is it studied?

Lee and colleagues (2015) described MOTS-c in association with a short open reading frame within the mitochondrial 12S ribosomal RNA region. Their experimental programme linked the peptide to folate/purine metabolism and AMPK-associated signalling in defined cellular and mouse models. The work advanced a hypothesis about mitochondrial–nuclear communication; it did not establish that MOTS-c directly binds AMPK or that all downstream effects follow one mechanism.

The material in a paper may be endogenous peptide measured in cells, a chemically synthesised research peptide introduced into a model, or another distinct preparation. Those exposure conditions should be recorded before interpreting results or matching them to a commercial product.

Three evidence layers from the founding studies

Study Model and principal question Finding to interpret What the result does not establish
Lee et al., 2015 Cell and mouse metabolic models Connections involving folate/purine metabolism, AMPK-associated signalling and measured metabolic responses Direct AMPK binding or a human intervention effect
Kim et al., 2018 Metabolic stress, cellular localisation and gene-expression systems Stress-responsive nuclear localisation with AMPK dependence and NRF2-associated transcriptional context A universal change in every cell type or organism
Reynolds et al., 2021 Human exercise observation; separate mouse/cell experiments Endogenous MOTS-c measurements with exercise; other experimental findings in animals and cells Efficacy from supplying MOTS-c to a human subject

This comparison is study architecture, not a combined efficacy estimate. The research models were different, and none of these studies authenticates a Core Research vial or pen.

Metabolic signalling: separate enzyme pathways from outcomes

In the 2015 work, a series of observations connected MOTS-c with folate- and purine-related processes and an AMPK-associated response. A reduction in a metabolic intermediate, a signalling-marker change and an organism-level mouse outcome are different measurements. Association between them can motivate a causal experiment, but it should not be rewritten as evidence that MOTS-c directly activates every named protein.

For a meaningful comparison of experimental results, identify the starting metabolic stress, the exact tested material, whether the study measured endogenous expression or added peptide, the controls and the measured endpoint. A claimed “metabolism boost” is neither a scientific measurement nor a description of the supplied material.

Nuclear localisation and transcriptional response

Kim and colleagues (2018) investigated the behaviour of MOTS-c under metabolic stress and reported movement to the nucleus in an AMPK-dependent context, with changes to stress-responsive gene expression. The paper examined interactions relevant to antioxidant-response regulation, including NRF2-associated transcriptional systems.

It matters whether a finding is localisation, transcript abundance or a downstream functional consequence. A peptide being detected in a nucleus does not by itself demonstrate a therapeutic property, nor does every gene-expression association establish a direct transcription-factor target.

What did the human exercise component actually measure?

Reynolds and colleagues (2021) collected muscle and circulating samples around exercise in a small cohort of healthy volunteers and assessed naturally occurring MOTS-c expression. The same publication reported separate experimental work in cultured cells and mice. Those study arms must not be merged into the statement that “MOTS-c was administered to people and improved performance”—that is not what the human exercise observation tested.

The paper is useful because it places endogenous MOTS-c within an exercise-response research question. Its mouse findings support specific animal-model conclusions, not a human intervention claim or the safety of a commercial lyophilised preparation.

Newer evidence: experimental host-defence activity in 2026

In an eLife article published in August 2026, Rice and colleagues investigated MOTS-c in antibacterial and immune-cell models. They reported interactions involving E. coli and MRSA, endogenous expression after immune stimulation, changes during monocyte-to-macrophage differentiation and findings from a mouse infection model. Their laboratory results extend the domain of possible MOTS-c research beyond the original metabolic framework.

There are important experimental conditions to retain. Antibacterial measurements included defined bacterial and solution environments, and interactions were sensitive to ionic conditions in parts of the work. The authors’ mechanistic experiments used a substantial amount of cell-line work, including THP-1 models. The independent eLife assessment requested further validation in primary cells. Therefore these findings do not prove that MOTS-c is a clinically validated antimicrobial, and they do not establish antibacterial performance of a supplied Core Research batch.

How to compare metabolism, exercise and host-defence papers

Before using a citation, specify the evidence layer and the relevant experimental boundary:

  1. Entity: Is MOTS-c the exact sequence and chemical form examined, or an endogenous antibody-based signal?
  2. Exposure: Was peptide introduced into the system, or measured as a naturally occurring response?
  3. Model: Was the material tested in a biochemical assay, cell line, primary cells, animal or human observation?
  4. Comparator: What control separated the proposed pathway effect from stress, vehicle or measurement artefact?
  5. Endpoint: Gene expression, localisation, bacterial aggregation, inflammation and physical capacity are not equivalent measures.
  6. Limit: What species, test conditions or follow-up work did the original researchers identify?

This framework helps a laboratory decide which paper speaks to its research question. It does not prescribe any experimental peptide preparation or personal-use method.

Distinguish literature identity from a supplied lot

A published sequence describes a research entity; a supplier’s product/batch record must establish the material offered in the relevant presentation. Verify the intended sequence and terminal form where specified, the lot, mass assignment, chromatographic evidence and any handling condition that the supplier actually documents. Do not assume that human exercise observations provide batch authentication or stability data.

Use Batch Documentation and the CoA-reading guide. The MOTS-c laboratory buffer/pH guide addresses separate method-dependent handling questions without converting this article into a preparation protocol.

Core Research formats and related material

The catalogue lists MOTS-c 40mg, MOTS-c Refill 40mg and MOTS-c 40mg Pen. Each finished presentation may need additional evidence beyond compound identity. The metabolism comparison distinguishes MOTS-c from NAD⁺, SS-31 and other materials whose primary biochemical questions are different.

Selected references

  1. Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015. DOI: 10.1016/j.cmet.2015.02.009. Cell/mouse evidence.
  2. Kim KH et al. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism, 2018. DOI: 10.1016/j.cmet.2018.06.008.
  3. Reynolds JC et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 2021. DOI: 10.1038/s41467-020-20790-0. Human observational component and separate cell/mouse work.
  4. Rice MC et al. MOTS-c is a mitochondrial-encoded interferon-linked host defense peptide. eLife, 2026. DOI: 10.7554/eLife.87615. Experimental host-defence models.